In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way Citeline uses cookies please go to our Cookie Policy page.


By closing this message, you are consenting to our use of cookies.

Close
 
 
 

Request a Demo of Citeline

By ticking this box, you agree to receive emails such as relevant news, updates and offers from Citeline, and carefully selected similar products from our portfolio.

By ticking this box, you agree to receive emails such as promotional offers from other members of the Informa group and selected 3rd party companies.

Whitepapers

Citeline's expert analysts regularly produce reports on key aspects of the industry, new therapy developments and trends. Enjoy free access to these insights by downloading our latest whitepapers below.

Raise Awareness for Parkinson’s Drug Development on Moving Day®

An analysis into the current clinical development landscape for Parkinson's disease. Is there hope for potential new therapies in the near future and beyond?

Raise Awareness for Parkinson’s Drug Development on Moving Day® Download

Innovation in Heart Failure Drug Development – Is There Enough?

An examination into the landscape of the pharmaceutical industry's new drug development and clinical trial activity in heart failure.

Innovation in Heart Failure Drug Development – Is There Enough? Download

Pediatric Type 2 Diabetes Trials: Are We Content with the Bare Minimum?

An exploration of the key sponsors of type 2 diabetes trials that enroll pediatric patients, the trial locations, and whether or not these
trials are only for postmarketing requirements.

Pediatric Type 2 Diabetes Trials: Are We Content with the Bare Minimum? Download

2013 Clinical Trials Scoreboard

A review of the 2013 clinical trials activity - a visual approach to profiling 2013, highlighting the overall trial activity across the entire industry as well as individual trial activity for the top 10 pharma companies.

2013 Clinical Trials Scoreboard Download

Changing Tides in Hepatitis C Virus (HCV) Treatment: The New Wave of HCV Drugs and Effects on Enrollment Trends

An exploration of enrollment trends in HCV trials, specifically the experience of the most active industry
sponsors and the effect that interferon and antivirals has had on recruitment rates over time.

Changing Tides in Hepatitis C Virus (HCV) Treatment: The New Wave of HCV Drugs and Effects on Enrollment Trends Download

New Active Substances Launched During 2013

An analysis of the industry’s success stories for 2013 – the drugs which were approved and launched on to the market for the first time during the year.

New Active Substances Launched During 2013 Download

Recent Trends in Personalized Medicine: Increasing Clinical Use and Impact of Pharmacogenomic and Epigenetic Biomarkers in Oncology

An examination of oncology clinical trials identifying, testing or using pharmacogenomic (PGX) biomarkers to either select or stratify patients.

Recent Trends in Personalized Medicine: Increasing Clinical Use and Impact of Pharmacogenomic and Epigenetic Biomarkers in Oncology Download

Citeline Pharma R&D Annual Review 2014

Citeline’s annual review of trends in pharmaceutical research and development. Ian Lloyd examines how the pipeline changed in 2013, and anticipates what 2014 might bring.

Citeline Pharma R&D Annual Review 2014 Download

Is Achieving Trial Success a Roll of the Dice? Dissecting Trials with Positive Outcomes to Identify Strategies for Success.

An examination of Autoimmune/Inflammation clinical trial-level success rates to date. This report tries to identify strategies that may correlate with success.

Is Achieving Trial Success a Roll of the Dice? Dissecting Trials with Positive Outcomes to Identify Strategies for Success. Download

Growing Opportunities to Meet Unmet Needs

A summary of clinical development for rare diseases in growing markets with unmet needs including Lupus, Cystic Fibrosis and Sjogren's Syndrome.

Growing Opportunities to Meet Unmet Needs Download

Rare Disease Landscape: Will the Blockbuster Model Be Replaced?

An analysis of the landscape of drug development for rare diseases, including the density of development by phase, developing company and disease, including a discussion on some of the reasons drug developers are going after rare diseases.

Rare Disease Landscape: Will the Blockbuster Model Be Replaced? Download

Dislipidaemia Development: A New Wave to Ride or a Tsunami of Disappointment?

An examination of late stage dyslipidaemia research to identify current trends and determine which near-term compound look the most encouraging.

Dislipidaemia Development: A New Wave to Ride or a Tsunami of Disappointment? Download

HIV Turns 30: What’s the Current State of Vaccine Research?

A review of the current landscape of HIV vaccine research for prevention and treatment, to determine if the field has rebounded from the setbacks of the STEP and ORVACS 002 trials. Trends in prophylactic and therapeutic vaccine clinical research are also revealed. Is gene therapy research a potential alternative to a therapeutic vaccine?

HIV Turns 30: What’s the Current State of Vaccine Research? Download

Lupus Clinical Development: Will Benlysta’s Approval Catalyze a New Paradigm for SLE

A profile of the drugs and clinical trials making up the current SLE landscape. How is Benlysta shaping the future of SLE drug development and providing a window onto the continued unmet need for many patients suffering from this diverse disease?

Lupus Clinical Development: Will Benlysta’s Approval Catalyze a New Paradigm for SLE Download

Rising to the Challenge:An Analysis of the Influenza Vaccine Landscape in Response to the Swine Flu Pandemic

Citeline evaluates the methods manufacturers pursued in response to the swine flu pandemic, with an analysis of alternate manufacturing methods and routes of administration. Have the major players in influenza vaccines shifted?

Rising to the Challenge:An Analysis of the Influenza Vaccine Landscape in Response to the Swine Flu Pandemic Download

Multiple Sclerosis Landscape: Is there a paradigm shift?

Citeline examines the clinical trials activity for MS looking to discern any trends or paradigm shifts that reflect the patient segments being investigated.

Multiple Sclerosis Landscape: Is there a paradigm shift? Download

ASCO 2013 Annual Meeting Roundup and What Made Waves

Immunotherapeutic drugs took center stage this year at The 49th Annual ASCO Meeting. This report provides an overview of the trials reported, looks at some of the individual drug highlights and analyses the distribution of investigators in those trials.

ASCO 2013 Annual Meeting Roundup and What Made Waves Download

Alzheimer’s New Paradigm: Hit the Target before the Symptoms

Citeline explores the current drug development landscape, the mechanisms of action, biomarkers, and top sponsors that are shaping Alzheimer’s treatment into the next three years.

Alzheimer’s New Paradigm: Hit the Target before the Symptoms Download

Trial Timing Benchmarks: Do Biomarker Outcomes Make a Difference?

Citeline analyzes benchmark data for oncology trials whose protocols include or omit objectives of identifying prognostic or predictive biomarkers, or endpoints involving biomarkers to assess efficacy or toxicity.

Trial Timing Benchmarks: Do Biomarker Outcomes Make a Difference? Download

Navigating FDA Guidance for Cardiovascular Safety in Type 2 Diabetes – What is the Best Strategy?

Cardiovascular safety is a critical factor in T2D new drug research. This report outlines the mixed successes sponsors have had while navigating new FDA requirements.

Navigating FDA Guidance for Cardiovascular Safety in Type 2 Diabetes – What is the Best Strategy? Download

Submit your details to download articles

By ticking this box, you agree to receive emails such as relevant news, updates and offers from Citeline, and carefully selected similar products from our portfolio.

By ticking this box, you agree to receive emails such as promotional offers from other members of the Informa group and selected 3rd party companies.